Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
4DMedical Ltd ( (AU:4DX) ) has shared an update.
4DMedical Limited has issued nearly 15 million shares as part of the earnout consideration for its acquisition of Imbio Inc. This strategic move is expected to strengthen 4DMedical’s position in the healthcare industry, particularly in the field of lung health, by integrating Imbio’s capabilities and expanding its technological offerings.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited operates in the healthcare industry, focusing on innovative lung health solutions. The company is known for its advanced medical imaging technology that enhances the diagnosis and treatment of respiratory conditions, aiming to improve patient outcomes in the respiratory health market.
Average Trading Volume: 967,811
Technical Sentiment Signal: Sell
Current Market Cap: A$157.7M
Learn more about 4DX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue